These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6086193)

  • 41. Blood pressure responses of conscious normotensive and spontaneously hypertensive rats to intracerebroventricular and peripheral administration of captopril.
    Hutchinson JS; Mendelsohn FA; Doyle AE
    Hypertension; 1980; 2(4):546-50. PubMed ID: 6995295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute effects of captopril on serum angiotensin-converting enzyme activity, the renin-aldosterone system and blood pressure in patients with sarcoidosis.
    Mizuno K; Gotoh M; Matsui J; Nagasawa S; Fukuchi S
    Tohoku J Exp Med; 1983 May; 140(1):107-8. PubMed ID: 6306866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The renin--angiotensin--aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC; Morton JJ
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():95s-99s. PubMed ID: 7004744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin-converting enzyme blockade by Captopril changes angiotensin II receptors and angiotensinogen concentrations in the brain of SHR-sp and WKY rats.
    Felix D; Schelling P
    Neurosci Lett; 1982 Dec; 34(1):45-50. PubMed ID: 6298670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.
    Baer L; Radichevich I; Williams GS
    J Cardiovasc Pharmacol; 1980; 2 Suppl 2():S206-16. PubMed ID: 6156357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat.
    Marks ES; Bing RF; Thurston H; Swales JD
    Clin Sci (Lond); 1980 Jan; 58(1):1-6. PubMed ID: 6986224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypotensive action of captopril in spontaneously hypertensive and normotensive rats. Interference with neurogenic vasoconstriction.
    Clough DP; Hatton R; Keddie JR; Collis MG
    Hypertension; 1982; 4(6):764-72. PubMed ID: 6292083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the converting-enzyme inhibitor SQ 14 225 (captopril) in early one-kidney, one-clip hypertension in the rat.
    Vandongen R; Tunney A; Martinez P
    Clin Sci (Lond); 1981 Apr; 60(4):387-92. PubMed ID: 7018794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of captopril on blood pressure, urinary water and electrolyte excretion and drinking behaviour in Brattleboro rats.
    Gardiner SM; Bennett T
    Clin Sci (Lond); 1983 Dec; 65(6):589-97. PubMed ID: 6354558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different effects of captopril on blood pressure in the acute and chronic two-kidney Goldblatt hypertensive dogs.
    Ohara N; Ono H; Hashimoto K
    Jpn Circ J; 1982 Jul; 46(7):706-14. PubMed ID: 7047789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
    Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
    Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
    McCaa RE
    Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Converting enzyme inhibition in mild and moderate essential hypertension. II.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand; 1986; 219(1):29-36. PubMed ID: 3006449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of hypotensive mechanisms of captopril in addition to its inhibition of the converting enzyme in spontaneously hypertensive rats.
    Mikami H; Ogihara T; Ohde H; Naka T; Kumahara Y
    Jpn Circ J; 1982 Nov; 46(11):1154-8. PubMed ID: 6182310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response.
    Boomsma F; de Bruyn JH; Derkx FH; Schalekamp MA
    Clin Sci (Lond); 1981 May; 60(5):491-8. PubMed ID: 6265138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.